New platform for cerebral blood flow launched

NovaSignal, a medical technology and data company specialising in assessing cerebral blood flow, has launched the NovaGuide 2 Platform that aims to empower clinical teams with critical, real-time information about cerebral blood flow to guide diagnosis and improve patient outcomes. 

Designed to seamlessly integrate into existing clinical practice, the platform includes the NovaGuide 2 Intelligent Ultrasound which autonomously captures blood flow data to identify brain illnesses and disease, and NovaGuide View which provides secure, cloud-based access to dynamic exam data.

Using NovaSignal’s FDA-cleared, CE-marked, robotic ultrasound technology, the NovaGuide 2 Intelligent Ultrasound is a unified, AI-driven cerebral ultrasound solution that provides clinical teams with evidence to guide patient diagnosis and treatment. 

Dr. Chirag Gandhi, Director of Neurosurgery at Westchester Medical Centre: “The automated NovaGuide broadens our capabilities to treat ruptured aneurysm patients by giving us the ability to monitor for vasospasm any time of the day or night. The technology also eliminates inter-operator variability in ultrasound assessments and ensures that any change such as emboli or reduced blood flow are monitored, allowing me to stay updated on patient status.”

Populated with data from NovaGuide, the cloud-based NovaGuide View aims to enable faster treatment times with on-demand access to dynamic exam data. The interactive application improves co-ordination of clinical teams and reduces time to intervention with secure access to exam snapshots, videos, audio, and reports. Designed by data security experts, NovaGuide View ensures NovaGuide 2 Intelligent Ultrasound data is uploaded and stored in a secure, HIPAA-compliant cloud for instant viewing on the personal devices of the clinical team.

NovaSignal chairman and CEO, Diane Bryant, said: “Technology, data, and AI are transforming the way care is administered, resulting in improved patient outcomes. Cerebral blood flow data collected through our AI-driven, robotic ultrasound system is of tremendous value to clinical teams as they strive to reduce time to treatment. Our technology allows them to easily and rapidly identify the existence of stroke-causing events by providing a direct view into the brain. The mission of NovaSignal is to unlock the power of blood flow data.”